Articles by Disease (Brain Injuries)

Disruption of Zinc Neuromodulation by Aß Oligomers : Therapeutic Implications

Journal: Current Pharmaceutical Design
Volume: 20
Page: 2520-2524
Author(s): Emily C. Vogler and Jorge Busciglio

In Vivo Application of beta Amyloid Oligomers: A Simple Tool to Evaluate Mechanisms of Action and New Therapeutic Approaches

Journal: Current Pharmaceutical Design
Volume: 20
Page: 2491-2505
Author(s): Claudia Balducci and Gianluigi Forloni

The Vascular Component of Alzheimer`s Disease

Journal: Current Neurovascular Research
Volume: 11
Page: 168-176
Author(s): Dafin Fior Muresanu, Aurel Popa-Wagner, Adina Stan, Ana-Maria Buga and Bogdan Ovidiu Popescu

Mesenchymal Stromal Cell Therapy for Cardio Renal Disorders

Journal: Current Pharmaceutical Design
Volume: 20
Page: 2412-2429
Author(s): Marlies E.J. Reinders, Danielle G. Leuning, Johan W. de Fijter, Martin.J. Hoogduijn and Ton J. Rabelink

Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review

Journal: Current Pharmaceutical Design
Volume: 20
Page: 2218-2230
Author(s): Latha Velayudhan, Erik Van Diepen, Mangesh Marudkar, Oliver Hands, Srinivas Suribhatla, Richard Prettyman, Jonathan Murray, Sarah Baillon and Sagnik Bhattacharyya

Modulation of Transient Receptor Potential Vanilloid Subtype 1 (TRPV₁) and Norepinephrine Transporters (NET) Protect Against Oxidative Stress, Cellular Injury, and Vascular Dementia

Journal: Current Neurovascular Research
Volume: 11
Page: 94-106
Author(s): Surbhi Gupta, Bhupesh Sharma, Prabhat Singh and Brij Mohan Sharma

Reduction in Ischemic Cerebral Infarction is Mediated through Golgi Phosphoprotein 3 and Akt/mTOR Signaling Following Salvianolate Administration

Journal: Current Neurovascular Research
Volume: 11
Page: 107-113
Author(s): Hong You, Ting Li, Jinnan Zhang, Qiang Lei, Xi Tao, Pinghui Xie and Wei Lu